{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T10:42:00Z","timestamp":1772620920418,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":380,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.chembiol.2020.04.006","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T10:37:50Z","timestamp":1588847870000},"page":"780-792.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1"],"prefix":"10.1016","volume":"27","author":[{"given":"Zongyi","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Rolt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek J.","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Bum","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Southall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Eric","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel C.","family":"Talley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Marugan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Jake","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2020.04.006_bib1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20021756","article-title":"Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes","volume":"197","author":"Bartosch","year":"2003","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.chembiol.2020.04.006_bib2","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1128\/JVI.72.5.3827-3836.1998","article-title":"Hepatitis C virus structural proteins assemble into viruslike particles in insect cells","volume":"72","author":"Baumert","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2020.04.006_bib3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/AAC.02083-13","article-title":"A small-molecule inhibitor of hepatitis C virus infectivity","volume":"58","author":"Bush","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.chembiol.2020.04.006_bib4","doi-asserted-by":"crossref","first-page":"e1007759","DOI":"10.1371\/journal.ppat.1007759","article-title":"Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus","volume":"15","author":"Cao","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.chembiol.2020.04.006_bib5","series-title":"Amber 2018 Reference Manual","author":"Case","year":"2018"},{"key":"10.1016\/j.chembiol.2020.04.006_bib6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41598-017-00320-7","article-title":"A biologically-validated HCV E1E2 heterodimer structural model","volume":"7","author":"Castelli","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chembiol.2020.04.006_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.antiviral.2014.06.014","article-title":"Benzhydrylpiperazine compounds inhibit cholesterol-dependent cellular entry of hepatitis C virus","volume":"109","author":"Chamoun-Emanuelli","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.chembiol.2020.04.006_bib8","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.chembiol.2020.04.006_bib9","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1101\/gr.849004","article-title":"WebLogo: a sequence logo generator","volume":"14","author":"Crooks","year":"2004","journal-title":"Genome Res."},{"key":"10.1016\/j.chembiol.2020.04.006_bib10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/1615-9861(200101)1:1<108::AID-PROT108>3.0.CO;2-5","article-title":"Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. II. Limitations of complex mixture analyses","volume":"1","author":"Davis","year":"2001","journal-title":"Proteomics"},{"key":"10.1016\/j.chembiol.2020.04.006_bib11","doi-asserted-by":"crossref","first-page":"e1006908","DOI":"10.1371\/journal.ppat.1006908","article-title":"A protein coevolution method uncovers critical features of the hepatitis C virus fusion mechanism","volume":"14","author":"Douam","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.chembiol.2020.04.006_bib12","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1099\/vir.0.82567-0","article-title":"Mutagenesis of a conserved fusion peptide-like motif and membrane-proximal heptad-repeat region of hepatitis C virus glycoprotein E1","volume":"88","author":"Drummer","year":"2007","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.chembiol.2020.04.006_bib13","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1128\/jvi.68.10.6147-6160.1994","article-title":"Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses","volume":"68","author":"Dubuisson","year":"1994","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2020.04.006_bib14","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1038\/ncomms5874","article-title":"Unexpected structure for the N-terminal domain of hepatitis C virus envelope glycoprotein E1","volume":"5","author":"El Omari","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2020.04.006_bib15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature05654","article-title":"Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry","volume":"446","author":"Evans","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2020.04.006_bib16","doi-asserted-by":"crossref","first-page":"10333","DOI":"10.1128\/JVI.00991-15","article-title":"Hepatitis C virus envelope glycoprotein E1 forms trimers at the surface of the virion","volume":"89","author":"Falson","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2020.04.006_bib17","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1128\/JVI.73.8.6235-6244.1999","article-title":"Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, Cd81","volume":"73","author":"Flint","year":"1999","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2020.04.006_bib18","doi-asserted-by":"crossref","first-page":"e02309","DOI":"10.1128\/JVI.02309-16","article-title":"Computational prediction of the heterodimeric and higher-order structure of gpE1\/gpE2 envelope glycoproteins encoded by hepatitis C virus","volume":"91","author":"Freedman","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2020.04.006_bib19","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1128\/AAC.00556-10","article-title":"Resistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in\u00a0vitro replicon system","volume":"54","author":"Fridell","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.chembiol.2020.04.006_bib20","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/hep.24594","article-title":"Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in humans: in\u00a0vitro and in\u00a0vivo correlations","volume":"54","author":"Fridell","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.chembiol.2020.04.006_bib21","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1128\/JVI.00049-11","article-title":"Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A","volume":"85","author":"Gottwein","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2020.04.006_bib22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1126\/science.aal2712","article-title":"A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertion","volume":"358","author":"Guardado-Calvo","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2020.04.006_bib23","doi-asserted-by":"crossref","first-page":"282ra249","DOI":"10.1126\/scitranslmed.3010286","article-title":"Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection","volume":"7","author":"He","year":"2015","journal-title":"Sci. Trans. Med."},{"key":"10.1016\/j.chembiol.2020.04.006_bib24","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1021\/acs.jmedchem.5b00752","article-title":"Discovery, optimization, and characterization of novel chlorcyclizine derivatives for the treatment of hepatitis C virus infection","volume":"59","author":"He","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2020.04.006_bib25","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1073\/pnas.0832180100","article-title":"Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles","volume":"100","author":"Hsu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.chembiol.2020.04.006_bib26","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1128\/AAC.02094-13","article-title":"Novel cell-based hepatitis C virus infection assay for quantitative high-throughput screening of anti-hepatitis C virus compounds","volume":"58","author":"Hu","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.chembiol.2020.04.006_bib27","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/molbev\/mst010","article-title":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability","volume":"30","author":"Katoh","year":"2013","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.chembiol.2020.04.006_bib28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature13117","article-title":"Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2","volume":"509","author":"Khan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2020.04.006_bib29","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1126\/science.1243876","article-title":"Hepatitis C virus E2 envelope glycoprotein core structure","volume":"342","author":"Kong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2020.04.006_bib30","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1074\/jbc.M509747200","article-title":"Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes","volume":"281","author":"Lavillette","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2020.04.006_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1423-0127-16-89","article-title":"Mutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: involvement in cell fusion and virus entry","volume":"16","author":"Li","year":"2009","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.chembiol.2020.04.006_bib32","doi-asserted-by":"crossref","first-page":"16410","DOI":"10.1073\/pnas.0907439106","article-title":"A genome-wide genetic screen for host factors required for hepatitis C virus propagation","volume":"106","author":"Li","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.chembiol.2020.04.006_bib33","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.1073\/pnas.1602701113","article-title":"Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition","volume":"113","author":"Li","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.chembiol.2020.04.006_bib34","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.tim.2014.01.008","article-title":"A novel membrane fusion protein family in Flaviviridae?","volume":"22","author":"Li","year":"2014","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.chembiol.2020.04.006_bib35","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1056\/NEJMra1213651","article-title":"Current and future therapies for hepatitis C virus infection","volume":"368","author":"Liang","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chembiol.2020.04.006_bib36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2020.04.006_bib37","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1128\/JVI.01888-08","article-title":"Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection","volume":"83","author":"Liu","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2020.04.006_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/hep.22987","article-title":"Mutations in the hepatitis C virus polymerase that increase RNA binding can confer resistance to cyclosporine A","volume":"50","author":"Liu","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.chembiol.2020.04.006_bib39","doi-asserted-by":"crossref","first-page":"e01552-16","DOI":"10.1128\/JVI.01552-16","article-title":"Native folding of a recombinant gpe1\/gpe2 heterodimer vaccine antigen from a precursor protein fused with Fc IgG","volume":"91","author":"Logan","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2020.04.006_bib40","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm.2341","article-title":"EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy","volume":"17","author":"Lupberger","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.chembiol.2020.04.006_bib41","doi-asserted-by":"crossref","first-page":"10777","DOI":"10.1073\/pnas.1301764110","article-title":"Identification of transferrin receptor 1 as a hepatitis C virus entry factor","volume":"110","author":"Martin","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.chembiol.2020.04.006_bib42","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1053\/j.gastro.2009.04.048","article-title":"Amphipathic DNA polymers inhibit hepatitis C virus infection by blocking viral entry","volume":"137","author":"Matsumura","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chembiol.2020.04.006_bib43","doi-asserted-by":"crossref","first-page":"11571","DOI":"10.1128\/JVI.01717-06","article-title":"Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles","volume":"80","author":"Meertens","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2020.04.006_bib44","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1074\/mcp.M113.034710","article-title":"Expanding proteome coverage with orthogonal-specificity alpha-lytic proteases","volume":"13","author":"Meyer","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.chembiol.2020.04.006_bib45","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.chembiol.2020.04.006_bib46","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a lamarckian genetic algorithm and empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.chembiol.2020.04.006_bib47","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1021\/bi0523963","article-title":"The membrane-active regions of the hepatitis C virus E1 and E2 envelope glycoproteins","volume":"45","author":"Perez-Berna","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2020.04.006_bib48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hep.28111","article-title":"Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1","volume":"63","author":"Perin","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.chembiol.2020.04.006_bib49","doi-asserted-by":"crossref","first-page":"D593","DOI":"10.1093\/nar\/gkr859","article-title":"ViPR: an open bioinformatics database and analysis resource for virology research","volume":"40","author":"Pickett","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.chembiol.2020.04.006_bib50","doi-asserted-by":"crossref","first-page":"e01914","DOI":"10.1128\/JVI.01914-16","article-title":"Clinically approved ion channel inhibitors close gates for hepatitis C virus and open doors for drug repurposing in infectious viral diseases","volume":"91","author":"Pietschmann","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2020.04.006_bib51","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2020.04.006_bib52","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nature07684","article-title":"Human occludin is a hepatitis C virus entry factor required for infection of mouse cells","volume":"457","author":"Ploss","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2020.04.006_bib100","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/nprot.2007.261","article-title":"Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips","volume":"2","author":"Rappsilber","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.chembiol.2020.04.006_bib53","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1128\/JVI.02524-06","article-title":"Characterization of hepatitis C virus subgenomic replicon resistance to cyclosporine in\u00a0vitro","volume":"81","author":"Robida","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2020.04.006_bib54","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.chembiol.2020.04.006_bib55","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/infdis\/jiy039","article-title":"Preclinical pharmacological development of chlorcyclizine derivatives for the treatment of hepatitis C virus infection","volume":"217","author":"Rolt","year":"2018","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chembiol.2020.04.006_bib56","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/pmic.200300780","article-title":"Purification of biotinylated proteins on streptavidin resin: a protocol for quantitative elution","volume":"4","author":"Rybak","year":"2004","journal-title":"Proteomics"},{"key":"10.1016\/j.chembiol.2020.04.006_bib57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nm.2581","article-title":"Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor","volume":"18","author":"Sainz","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.chembiol.2020.04.006_bib58","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","article-title":"The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus","volume":"21","author":"Scarselli","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.chembiol.2020.04.006_bib59","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1016\/j.vaccine.2007.08.053","article-title":"Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies","volume":"25","author":"Stamataki","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.chembiol.2020.04.006_bib60","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3389\/fimmu.2018.01411","article-title":"Role of hepatitis C virus\u00a0envelope glycoprotein E1 in virus entry and assembly","volume":"9","author":"Tong","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.chembiol.2020.04.006_bib61","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1128\/JVI.80.4.1734-1741.2006","article-title":"Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry","volume":"80","author":"Tscherne","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2020.04.006_bib62","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1021\/jo402600b","article-title":"Diazirine-containing photoactivatable isoprenoid: synthesis and application in studies with isoprenylcysteine carboxyl methyltransferase","volume":"79","author":"Vervacke","year":"2014","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.chembiol.2020.04.006_bib63","doi-asserted-by":"crossref","first-page":"10159","DOI":"10.1128\/JVI.01180-10","article-title":"Characterization of the envelope glycoproteins associated with infectious hepatitis C virus","volume":"84","author":"Vieyres","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2020.04.006_bib64","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.chembiol.2020.04.006_bib65","series-title":"Global Hepatitis Report, 2017","author":"WHO","year":"2017"},{"key":"10.1016\/j.chembiol.2020.04.006_bib66","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/gutjnl-2013-306155","article-title":"Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C","volume":"64","author":"Xiao","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.chembiol.2020.04.006_bib67","first-page":"5.8.1","article-title":"Protein structure and function prediction using I-TASSER","volume":"52","author":"Yang","year":"2015","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.chembiol.2020.04.006_bib68","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.gastro.2016.09.033","article-title":"Infection of hepatocytes with HCV increases cell surface levels of heparan sulfate proteoglycans, uptake of cholesterol and lipoprotein, and virus entry by up-regulating smad6 and smad7","volume":"152","author":"Zhang","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chembiol.2020.04.006_bib69","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","article-title":"Robust hepatitis C virus infection in\u00a0vitro","volume":"102","author":"Zhong","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945620301434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945620301434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:36:19Z","timestamp":1762526179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945620301434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":70,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2451945620301434"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2020.04.006","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2020.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}